Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine XR for chronic somatoform pain disorder
ACTRN12610000603011Phase 3Terminated
- Sponsor
- Dr Peter Farnbach
- Start
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic pain comparing Quetiapine XR adjunctive therapy with Placebo adjunctive therapy (2 arms). Primary endpoint: Pain intensity response on numerical rating scale for pain. Started Aug 2011; status: terminated.
02
Drugs
quetiapine
03
Conditions
chronic pain
Beyond the preview
Go deeper on ACTRN12610000603011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000603011.